US 11123283
Soluble estradiol capsule for vaginal insertion
granted A61KA61K31/565A61K31/57
Quick answer
US patent 11123283 (Soluble estradiol capsule for vaginal insertion) held by Compass Therapeutics LLC expires Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Compass Therapeutics LLC
- Grant date
- Tue Sep 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/565, A61K31/57, A61K47/10, A61K47/14